PMID- 16409846
OWN - NLM
STAT- MEDLINE
DCOM- 20080220
LR  - 20060113
IS  - 0376-2491 (Print)
IS  - 0376-2491 (Linking)
VI  - 85
IP  - 47
DP  - 2005 Dec 14
TI  - [Effect of surgical treatment of tricuspid regurgitation late after valve 
      replacement of left heart].
PG  - 3362-4
AB  - OBJECTIVE: To investigate the appropriate methodology and outcome of surgical 
      treatment of tricuspid regurgitation late after valve replacement of left heart. 
      METHODS: Eighteen patients with tricuspid insufficiency, with the diagnosis 
      conformed by echocardiogram and in New York Heart Association (NYHA) class III to 
      IV, were treated surgically 3 to 14 years after left heart valve replacement, 
      including 13 mitral valve replacements and 5 double valve replacements, from 
      January 1995 to May 2004. DeVega was used in 5 patients. The ages at the time of 
      tricuspid surgery ranged from 35 to 65 years (median 50 years). The patients were 
      followed up for 36.7 months (12-114 months). RESULTS: There was no death from 
      hemorrhage because of re-open. Tricuspid repair was performed in 8 patients, 
      tricuspid replacement was done in 10 patients, 5 bioprostheses and 5 mechanical 
      valves were implanted. The hospital mortality was 16.7%. Among the survivors, the 
      three-year survival rate was 78.8%. Twelve patients showed improvement of 
      symptoms, while there was no improvement in 3 patients who needed medical 
      therapy. CONCLUSION: The pathophysiology of tricuspid regurgitation is associated 
      with delayed left heart operation, implement of tricuspid repair in the first 
      operation or progressive right ventricular failure. The surgical intervention 
      should be earlier before the onset of severe right ventricular failure Tricuspid 
      valve repair is the procedure of choice, while tricuspid valve replacement is 
      also acceptable.
FAU - Hou, Xiao-tong
AU  - Hou XT
AD  - Department of Cardiac Surgery, Beijing An Zhen Hospital, Capital University of 
      Medical Science, Beijing 100029, China.
FAU - Meng, Xu
AU  - Meng X
FAU - Li, Wei
AU  - Li W
FAU - Wang, Jian-gang
AU  - Wang JG
LA  - chi
PT  - English Abstract
PT  - Journal Article
PL  - China
TA  - Zhonghua Yi Xue Za Zhi
JT  - Zhonghua yi xue za zhi
JID - 7511141
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cardiac Surgical Procedures/methods
MH  - Female
MH  - Follow-Up Studies
MH  - *Heart Valve Prosthesis Implantation
MH  - Hospital Mortality
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Mitral Valve/*surgery
MH  - Rheumatic Heart Disease/mortality/*surgery
MH  - Survival Rate
MH  - Tricuspid Valve Insufficiency/mortality/*surgery
EDAT- 2006/01/18 09:00
MHDA- 2008/02/21 09:00
CRDT- 2006/01/18 09:00
PHST- 2006/01/18 09:00 [pubmed]
PHST- 2008/02/21 09:00 [medline]
PHST- 2006/01/18 09:00 [entrez]
PST - ppublish
SO  - Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3362-4.